Identification of NAD+ Metabolism-Derived Gene Signatures in Ovarian Cancer Prognosis and Immunotherapy

Identification of NAD+ Metabolism-Derived Gene Signatures in Ovarian Cancer Prognosis and Immunotherapy

Background: Nicotinamide adenine dinucleotide (NAD+) has emerged as a critical regulator of cell signaling and survival pathways, affecting tumor initiation and progression. In this study it was investigated whether circulating NAD+ metabolism-related genes (NMRGs) could be used to predict immunothe...

Full description

Bibliographic Details
Main Authors: Liang Lin, Li Chen, Zuolian Xie, Jian Chen, Ling Li, An Lin
Format: Article
Language:English
Published: Frontiers Media S.A. 2022-06-01
Series:Frontiers in Genetics
Subjects:
NAD+
ovarian cancer
prognostic signature
biomarker
immunotherapy
Online Access:https://www.frontiersin.org/articles/10.3389/fgene.2022.905238/full

Internet

https://www.frontiersin.org/articles/10.3389/fgene.2022.905238/full

Similar Items